How to Offer Peptides (Safely) at Your Gym
Expand your gym's health and wellness offering with clinician-supported peptide care.
Peptide-related care is becoming part of the broader conversation around recovery, performance, metabolic health, and healthy aging. For gyms, it can be another way to expand the services you offer and give members access to support beyond the workout itself.
Considering peptide-related care for your gym? Here's what we’ll cover: what’s available to offer today, how 503A compounding works, how to introduce the service to members, and how to find the right clinical infrastructure.
Compounded peptides are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality. A peptide prescription is issued following evaluation by a licensed healthcare provider only when clinically appropriate.
Why Your Members Are Asking About Peptides
Your gym competes on more than equipment, location, and price. Members increasingly want support that extends past the workout itself, and they are actively searching for it.
How fast is the demand for peptides growing?
Quickly, and across every channel your members already pay attention to. According to Google Keyword Planner (2021 - 2026), search demand has climbed sharply over the past five years:
Search interest in peptides is up 399% over five years (Google Keyword Planner, 2021–2026).
Searches for Sermorelin, a peptide currently available for 503A compounding under existing FDA policy,rose 233% over the same time period.
Interest in adjacent longevity therapies like NAD+ is rising too, with NAD+ searches up 172% over the same window.
The broader longevity and wellness market sat near $63 billion in 2025 and is projected to reach roughly $106 billion by 2033, according to Grand View Research.
That interest is already walking through your doors. Members hear about peptides from podcasts, trainers, and social feeds, then look for somewhere they trust to ask about them.
What are gym members actually looking for?
Your members are wanting to feel and look better. They want help with recovery, performance, and healthy aging, and they’ve already built trust with you. Would rather get it somewhere they already trust than from an unknown website.
For gyms, meeting that demand can look like:
Recovery and performance support
Metabolic health and weight management
Healthy aging and longevity services
Hormone-related care
Sleep support
Other clinician-supported health and wellness programs
You don't need to build all of these yourself. A virtual care partner can provide the clinical infrastructure behind an expanded offering while your gym stays focused on the member experience.
For a broader look at high-demand programs, see our guide on clinical longevity services for gyms and five services that can grow gym revenue and member value.
The Regulatory State of Peptides
If you're considering offering your members access to peptide-related clinical services through licensed healthcare providers, the services available through that clinical model will depend on the medications involved and applicable federal and state requirements.
Bulk substances used in compounding have to meet specific conditions under federal law. For a compounded drug to qualify for the exemptions under 503A, a bulk drug substance generally must must:
Comply with an applicable USP or NF drug-substance monograph, if one exists
If the monograph doesn’t exist, be a component of an FDA-approved drug
Or, if neither condition applies, appear on the FDA’s 503A Bulks List. Separately, the FDA maintains an interim enforcement policy for certain nominated substances identified as "Category 1"
FDA’s regulatory treatment of certain peptide bulk drug substances has changed significantly since 2023. You don't need to be a compliance expert, but you should understand the basics before supporting, promoting or launching a peptide-related clinical program.
Here's how the last three years unfolded, from FDA’s 2023 category changes through the July 2026 PCAC votes:
Recommendation does not equal FDA approval
A favorable PCAC recommendation is not the same as FDA approval or present eligibility for 503A compounding. The committee's votes are non-binding, and a compounded drug made from one of these bulk substances generally cannot be legal unless another pathway applies or the FDA adds the bulk substance to the 503A Bulks List through rulemaking. That process generally includes a proposed rule, a public-comment period and a final rule. a proposed rule, a public comment period, and a final rule).
For certain substances nominated before January 7, 2025, the FDA uses three categories to describe their status under its interim enforcement policy. These categories do not themselves establish FDA approval or independently determine legal eligibility under 503A.
What’s The Difference Between Category 1, 2, and 3?
FDA Interim Category
What it means
Can it be compounded?
Category 1
Nominated with sufficient supporting information for FDA to evaluate and not preliminarily identified by FDA as presenting a significant safety risk.
Yes, FDA generally does not intend to take enforcement action based on use of the bulk substance when every condition in its interim policy and all other applicable §503A requirements are satisfied.(still not FDA-approved)
Category 2
FDA has identified significant safety risks associated with use of the substance in compounding.
No, The substance is outside FDA’s Category 1 enforcement-discretion policy.
Category 3
The nomination did not contain sufficient supporting information for FDA to evaluate the substance.
No, The substance is outside FDA’s Category 1 enforcement-discretion policy
What does Category 1 mean for prescribing?
Even Category 1 status is not FDA approval, nor does it mean that the substance or resulting compounded drug is safe or effective. It reflects an interim enforcement position under which the FDA generally does not intend to take action against a state-licensed pharmacy, federal outsourcing facility or licensed physicians compounding with the substance when all conditions of the policy are satisfied.
Those conditions include applicable manufacturer-registration and certificate of analysis requirements, in addition to the other 503A requirements.\
Category 1 status also does not override state law. State pharmacy, medical-practice, telehealth, prescribing and compounding requirements must be evaluated separately before a program is offered in a specific state.
Our recap of the July 2026 PCAC meeting discusses the substances considered, the committee’s nonbinding recommendations, and the additional FDA action that is necessary before the substances could qualify for 503A compounding.
How Does 503A Compounding Work?
A 503A compounding pharmacy is a state-licensed pharmacy that compounds patient-specific medications pursuant to valid prescriptions and in accordance with the conditions of , Section 503A of the Federal Food, Drug, and Cosmetic Act.
FDA explains that 503A compounders may use bulk drug substances only when the substances satisfy the applicable statutory conditions. A compounded drug is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality.
For a full walkthrough of how 503A pharmacies operate, what standards they're held to, and how they differ from 503B outsourcing facilities, see our guide: 503A Compounding Pharmacies: What They Are and How They Work
What Can Your Gym Offer Today?
Your gym can offer members access to clinician-supported peptide care without your staff providing the medical care themselves. The cleanest way to do that is to work with a qualified, White-Label clinical infrastructure partner that owns the clinical side.
To be clear about the line, a gym should never:
Diagnose members
Prescribe medication
Determine which peptide a member should use
Dispense compounded medication
Those functions belong within the appropriate clinical and pharmacy relationships.
On the substance side, bulk substances used in compounding have to meet specific conditions under federal law. Generally, they need to be a component of an FDA-approved drug, covered by an applicable USP/NF monograph, or fall under the FDA's interim compounding policy, often referred to by its "Category 1" designation.
As covered above, that policy isn't static. But the safe rule of thumb holds: offer what is compoundable under Category 1 today, and treat anything still moving through the FDA's process as future roadmap, not current menu.
What Does a Peptide Program Look Like at a Gym?
The clinical side stays with qualified clinicians while your gym manages the member experience. The exact workflow depends on your clinical model and pharmacy partner, but it usually follows this path:
Member expresses interest. Your gym introduces the service as an additional health and wellness resource.
Clinical evaluation. The member connects with a qualified clinician who evaluates whether treatment is appropriate based on their health history and clinical needs.
Treatment decision. The clinician determines the appropriate course of care. Your gym does not diagnose, prescribe, or decide which peptide a member should use.
Pharmacy fulfillment. When compounded medication is appropriate, the prescription moves through the applicable pharmacy pathway.
Ongoing care. The member continues care through the clinical program while your gym delivers the fitness, coaching, recovery, and accountability that support their broader goals.
Your job is the part you already do well: the relationship, the environment, and the results members show up for.
Should you build peptide programs in-house or with a white-label provider?
For businesses that don’t have the clinical infrastructure in place, a white-label partner is typically the better route. Building the clinical side yourself means credentialing clinicians, managing pharmacy relationships, and guiding compliance in every state your members live in, on top of running your gym.
A white-label partner runs all of that behind your brand. The program still fits seamlessly into your gym and feels like a natural part of the member experience, but you don't build or handle the clinical infrastructure. That gives your members the smoother experience and keeps the clinical operation off your plate.
How to Choose the Right White-Label Telehealth Partner for Your Peptide Program
A white-label telehealth partner can provide the clinical, technical, and operational infrastructure behind a program while your gym remains focused on your brand and member experience. The right partner should be able to support the program you want to launch today and the services you may want to add as demand grows.
Here are the key areas to evaluate:
Clinical Infrastructure and Provider Network
Why it matters:
The care delivered through a white-label program reflects on your gym's brand. Your partner should have the clinical infrastructure to support appropriate evaluation, prescribing, documentation, and ongoing care.
What to look for:
Licensed clinicians with appropriate state coverage
Provider credentialing and verification
Clinical oversight and quality processes
Clearly defined clinical workflows
Capacity to support growing member volume
Questions to ask:
How are clinicians recruited and credentialed?
How is clinical quality monitored?
Can the provider network support your target states?
Can the network scale as member demand grows?
Regulatory and Compliance Infrastructure
Why it matters:
Peptide programs operate within a regulatory environment that can vary by state and evolve over time. Your partner should have systems for monitoring and responding to those changes.
What to look for:
Multi-state licensure management
Appropriate prescribing safeguards
Compliance monitoring
Pharmacy coordination
Clear clinical and operational responsibilities
Questions to ask:
Who monitors regulatory changes?
How does the partner respond when a medication's status changes?
How are pharmacy relationships managed?
What compliance responsibilities remain with your gym?
Scalability and Breadth of Services
Why it matters:
Your members' needs may expand beyond the initial peptide offering. A partner that can support additional service lines can help you build on the program without replacing your infrastructure later.
What to look for:
Multi-state coverage
Capacity to handle increasing member volume
Additional health and wellness service lines
Flexible workflows
Ongoing operational support
Questions to ask:
Can the partner support additional states as you grow?
Can new service lines be added without rebuilding the program?
How much operational support will your team need to provide?
Technology and Member Experience
Why it matters:
The clinical infrastructure may sit behind your brand, but the member still experiences the program through the technology, communication, scheduling, and support provided by your partner.
What to look for:
White-label branding
Easy scheduling and intake
Secure patient communications
Integrated clinical workflows
Reporting and analytics
Ongoing member support
Your members should experience the program as a natural extension of your gym, rather than a disconnected third-party service.
Pharmacy and Fulfillment Support
Why it matters:
If compounded medication is part of the program, pharmacy coordination becomes part of the overall member experience.
What to look for:
Established pharmacy relationships
Clear fulfillment workflows
Communication around prescription status
Processes for handling pharmacy availability and changes
Clear definition of which organization manages each step
Your partner should be able to explain how pharmacy coordination works and what responsibilities remain with your gym.
Understand Who Handles What
Before launch, establish clear ownership across the entire member journey.
Your gym may remain responsible for:
Member relationship and brand experience
Making members aware of available services
Fitness, coaching, and recovery services
Coordination with your clinical partner
Your clinical infrastructure partner may manage:
Clinical evaluation
Licensed provider network
Prescribing when medically appropriate
Clinical documentation
Pharmacy coordination
Follow-up care
Clinical and regulatory workflows
The exact division of responsibilities will depend on your program structure and should be clearly defined before launch.
Build a Peptide Program With the Right Clinical Infrastructure
You don't need to build a medical practice inside your gym to give members access to clinician-supported peptide care.
A virtual care partner can provide the clinical infrastructure behind the program while your gym remains focused on the member relationship, fitness experience, and services you already provide.
OpenLoop® provides white-label virtual care infrastructure, including licensed clinicians, clinical workflows, pharmacy coordination, and technology designed to support healthcare programs at scale.
Whether you're adding recovery and performance services for the first time or expanding an existing wellness offering, the right clinical infrastructure can help you build the program without taking on the entire clinical operation yourself.
Ready to explore peptide care for your gym? Learn how OpenLoop can help you launch a clinically compliant program.
Compounded medications are not FDA-approved. FDA does not review compounded drugs for safety, efficacy, or quality before they are marketed. Compounded medications require a prescription following an appropriate clinical evaluation. No prescription is guaranteed. Peptide availability varies based on clinical appropriateness, applicable federal and state laws, pharmacy availability, and other regulatory requirements. Not all peptide therapies are available in all states or through all pharmacies. See our website for full details, important patient information, and applicable restrictions.
This content is for general informational purposes only and does not constitute legal or medical advice. Please consult your attorneys for legal guidance, and healthcare professionals for medical advice.
